Regulation of lung branching morphogenesis by bombesin-like peptides and neutral endopeptidase.
The expression of bombesin-like peptides (BLPs) by pulmonary neuroendocrine cells is transiently upregulated during lung development. A functional role for BLPs is supported by their ability to stimulate lung growth and maturation both in vitro and in vivo during the late stages of lung development. In addition, the cell membrane-associated enzyme CD10/neutral endopeptidase 24.11 (CD10/NEP), which inactivates BLPs and other regulatory peptides, is also expressed by developing lungs and modulates the stimulatory effects of BLPs on lung growth and maturation. We hypothesized that, in addition to expressing BLPs and CD10/NEP, embryonic lungs must express BLP receptors, and that BLPs may also regulate processes that occur during early lung development such as branching morphogenesis. Using reverse transcriptase-polymerase chain reaction and oligonucleotide primers designed for amplifying a BLP receptor originally isolated from Swiss 3T3 mouse fibroblasts, we found that embryonic mouse lungs express a similar BLP receptor mRNA during the pseudoglandular stage of lung development when branching morphogenesis take place. Subsequently, we evaluated the effects of ligands for this BLP receptor using embryonic mouse lungs in an in vitro model of lung branching morphogenesis. We found that, in comparison with control lungs, treatment with bombesin (1 to 100 nM) resulted in a modest increase in clefts or branching points. In contrast, embryonic mouse lungs treated with the BLP analog [Leu13-psi(CH2NH)Leu14]bombesin (1 microM), which also binds to this BLP receptor but has predominantly antagonistic effects, demonstrated fewer branching points.(ABSTRACT TRUNCATED AT 250 WORDS)
Aguayo
S M
SM
Department of Medicine, Atlanta Department of Veterans Affairs Medical Center, Decatur, GA 30033.
Schuyler
W E
WE
Murtagh
J J
JJ
Roman
J
J
D000818:Animals; D001483:Base Sequence; D001839:Bombesin / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000502:physiology; D002455:Cell Division / Q000187:drug effects; D004247:DNA / Q000032:analysis; D005260:Female; D006020:Glycopeptides / Q000494:pharmacology; D008168:Lung / Q000737:chemistry / Q000166:cytology / Q000196:embryology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D009024:Morphogenesis / Q000187:drug effects; D015260:Neprilysin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis; D018004:Receptors, Bombesin / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000235:genetics
D006020:Glycopeptides; D012333:RNA, Messenger; D018004:Receptors, Bombesin; C057644:bombesin, Leu(13)-psi-CH2NH-Leu(14)-; D004247:DNA; D015260:Neprilysin; D001839:Bombesin; C008890:phosphoramidon